TS-172

· Taisho Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for TS-172, covering 2025-02-28 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis [Phase 3]